![Figure 6 from Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. | Semantic Scholar Figure 6 from Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/41346ca5c0e64f392f16abeca897e0e1d85c74a0/51-Figure6-1.png)
Figure 6 from Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. | Semantic Scholar
![Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review - ScienceDirect Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253815563527-gr1.jpg)
Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review - ScienceDirect
Studying Medicine on Twitter: "Updated guidelines for mgt of restless legs syndrome (RLS) - For chronic persistent RLS in adults despite appropriate iron supplementation —> first-line therapy with alpha-2-delta calcium channel ligand (
![Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report - ScienceDirect Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1389945717315599-gr6.jpg)
Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report - ScienceDirect
![Choose treatment for restless legs syndrome based on patient and drug characteristics | SpringerLink Choose treatment for restless legs syndrome based on patient and drug characteristics | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40267-020-00773-3/MediaObjects/40267_2020_773_Fig1_HTML.png)
Choose treatment for restless legs syndrome based on patient and drug characteristics | SpringerLink
![Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation - ScienceDirect Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1389945716000563-sleep3013-fig-0001.jpg)
Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation - ScienceDirect
![Algorithms for the diagnosis and treatment of restless legs syndrome in primary care | BMC Neurology | Full Text Algorithms for the diagnosis and treatment of restless legs syndrome in primary care | BMC Neurology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2377-11-28/MediaObjects/12883_2010_Article_434_Fig3_HTML.jpg)